Literature DB >> 11435976

Xenogeneic extracellular matrix grafts elicit a TH2-restricted immune response.

A J Allman1, T B McPherson, S F Badylak, L C Merrill, B Kallakury, C Sheehan, R H Raeder, D W Metzger.   

Abstract

BACKGROUND: Porcine small intestinal submucosa (SIS) is an acellular, naturally derived extracellular matrix (ECM) that has been used for tissue remodeling and repair in numerous xenotransplantations. Although a vigorous immune response to xenogeneic extracellular matrix biomaterials is expected, to date there has been evidence for only normal tissue regeneration without any accompanying rejection. The purpose of this study was to determine the reason for a lack of rejection.
METHODS: Mice were implanted s.c. with xenogeneic tissue, syngeneic tissue, or SIS, and the graft site analyzed histologically for rejection or acceptance. Additionally, graft site cytokine levels were determined by reverse transcriptase polymerase chain reaction and SIS-specific serum antibody isotype levels were determined by ELISA.
RESULTS: Xenogeneically implanted mice showed an acute inflammatory response followed by chronic inflammation and ultimately graft necrosis, consistent with rejection. Syngeneically or SIS implanted mice, however, showed an acute inflammatory response that diminished such that the graft ultimately became indistinguishable from native tissue, observations that are consistent with graft acceptance. Graft site cytokine analysis showed an increase in interleukin-4 and an absence of interferon-gamma. In addition, mice implanted with SIS produced a SIS-specific antibody response that was restricted to the IgG1 isotype. Reimplantation of SIS into mice led to a secondary anti-SIS antibody response that was still restricted to IgG1. Similar results were observed with porcine submucosa derived from urinary bladder. To determine if the observed immune responses were T cell dependent, T cell KO mice were implanted with SIS. These mice expressed neither interleukin-4 at the implant site nor anti-SIS-specific serum antibodies but they did accept the SIS graft.
CONCLUSIONS: Porcine extracellular matrix elicits an immune response that is predominately Th2-like, consistent with a remodeling reaction rather than rejection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11435976     DOI: 10.1097/00007890-200106150-00024

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  101 in total

1.  Small intestinal submucosa seeded with intestinal smooth muscle cells in a rodent jejunal interposition model.

Authors:  Harry H Qin; James C Y Dunn
Journal:  J Surg Res       Date:  2011-08-27       Impact factor: 2.192

2.  Evaluation of porcine-derived small intestine submucosa as a biodegradable graft for gastrointestinal healing.

Authors:  Sebastian G de la Fuente; Marcia R Gottfried; D Curtis Lawson; Mary B Harris; Christopher R Mantyh; Theodore N Pappas
Journal:  J Gastrointest Surg       Date:  2003-01       Impact factor: 3.452

Review 3.  [Tissue engineering of the urethra and ureter].

Authors:  S Corvin; G Feil; A Stenzl
Journal:  Urologe A       Date:  2004-10       Impact factor: 0.639

Review 4.  A review of patch options in the repair of congenital diaphragm defects.

Authors:  Alessandra C Gasior; Shawn D St Peter
Journal:  Pediatr Surg Int       Date:  2012-04       Impact factor: 1.827

5.  Use of porcine small intestine submucosa as a prosthetic material for laparoscopic hernia repair in infected and potentially contaminated fields: long-term follow-up assessment.

Authors:  Morris Franklin; Karla Russek
Journal:  Surg Endosc       Date:  2011-05       Impact factor: 4.584

6.  Comparison of three methods for the derivation of a biologic scaffold composed of adipose tissue extracellular matrix.

Authors:  Bryan N Brown; John M Freund; Li Han; J Peter Rubin; Janet E Reing; Eric M Jeffries; Mathew T Wolf; Stephen Tottey; Christopher A Barnes; Buddy D Ratner; Stephen F Badylak
Journal:  Tissue Eng Part C Methods       Date:  2011-02-05       Impact factor: 3.056

7.  Repurposed biological scaffolds: kidney to pancreas.

Authors:  Bradley J Willenberg; Jose Oca-Cossio; Yunqing Cai; Alicia R Brown; William L Clapp; Dale R Abrahamson; Naohiro Terada; Gary W Ellison; Clayton E Mathews; Christopher D Batich; Edward A Ross
Journal:  Organogenesis       Date:  2015       Impact factor: 2.500

8.  Modulating adaptive immune responses to peptide self-assemblies.

Authors:  Jai S Rudra; Tao Sun; Katelyn C Bird; Melvin D Daniels; Joshua Z Gasiorowski; Anita S Chong; Joel H Collier
Journal:  ACS Nano       Date:  2012-01-30       Impact factor: 15.881

9.  Novel extra cellular-like matrices to improve human ovarian grafting.

Authors:  Ronit Abir; Dana Stav; Yossi Taieb; Rinat Gabbay-Benziv; Moria Kirshner; Avi Ben-Haroush; Enrique Freud; Shifra Ash; Isaac Yaniv; Michal Herman-Edelstein; Benjamin Fisch; Yoel Shufaro
Journal:  J Assist Reprod Genet       Date:  2020-07-24       Impact factor: 3.412

10.  In vitro characterization of a novel tissue engineered based hybridized nano and micro structured collagen implant and its in vivo role on tenoinduction, tenoconduction, tenogenesis and tenointegration.

Authors:  Ahmad Oryan; Ali Moshiri; Abdolhamid Meimandi-Parizi
Journal:  J Mater Sci Mater Med       Date:  2013-12-11       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.